Mutagenicity and carcinogenicity of biological reactive intermediate's derived from a "non-genotoxic" carcinogen.
Publication
, Journal Article
Lau, SS; Yoon, HS; Patel, SK; Everitt, JI; Walker, CL; Monks, TJ
Published in: Adv Exp Med Biol
2001
Duke Scholars
Published In
Adv Exp Med Biol
ISSN
0065-2598
Publication Date
2001
Volume
500
Start / End Page
83 / 92
Location
United States
Related Subject Headings
- Tumor Suppressor Proteins
- Tuberous Sclerosis Complex 2 Protein
- Repressor Proteins
- Mutagens
- Loss of Heterozygosity
- Kidney Neoplasms
- Kidney
- Hydroquinones
- Humans
- Glutathione
Citation
APA
Chicago
ICMJE
MLA
NLM
Lau, S. S., Yoon, H. S., Patel, S. K., Everitt, J. I., Walker, C. L., & Monks, T. J. (2001). Mutagenicity and carcinogenicity of biological reactive intermediate's derived from a "non-genotoxic" carcinogen. Adv Exp Med Biol, 500, 83–92.
Lau, S. S., H. S. Yoon, S. K. Patel, J. I. Everitt, C. L. Walker, and T. J. Monks. “Mutagenicity and carcinogenicity of biological reactive intermediate's derived from a "non-genotoxic" carcinogen.” Adv Exp Med Biol 500 (2001): 83–92.
Lau SS, Yoon HS, Patel SK, Everitt JI, Walker CL, Monks TJ. Mutagenicity and carcinogenicity of biological reactive intermediate's derived from a "non-genotoxic" carcinogen. Adv Exp Med Biol. 2001;500:83–92.
Lau, S. S., et al. “Mutagenicity and carcinogenicity of biological reactive intermediate's derived from a "non-genotoxic" carcinogen.” Adv Exp Med Biol, vol. 500, 2001, pp. 83–92.
Lau SS, Yoon HS, Patel SK, Everitt JI, Walker CL, Monks TJ. Mutagenicity and carcinogenicity of biological reactive intermediate's derived from a "non-genotoxic" carcinogen. Adv Exp Med Biol. 2001;500:83–92.
Published In
Adv Exp Med Biol
ISSN
0065-2598
Publication Date
2001
Volume
500
Start / End Page
83 / 92
Location
United States
Related Subject Headings
- Tumor Suppressor Proteins
- Tuberous Sclerosis Complex 2 Protein
- Repressor Proteins
- Mutagens
- Loss of Heterozygosity
- Kidney Neoplasms
- Kidney
- Hydroquinones
- Humans
- Glutathione